Standard Biotools (LAB) Income towards Parent Company (2010 - 2026)

Standard Biotools (LAB) has 17 years of Income towards Parent Company data on file, last reported at $141.7 million in Q1 2026.

• On a quarterly basis, Income towards Parent Company rose 5420.84% year-over-year to $141.7 million in Q1 2026; TTM through Mar 2026 was $106.2 million, a 237.62% increase from a year earlier, with the FY2025 full-year figure at -$58.8 million, up 57.05% from the prior year.
• Income towards Parent Company for Q1 2026 stood at $141.7 million, up from $13.9 million in the prior quarter.
• Over the last five years, Income towards Parent Company for LAB reached as high as $153.2 million in Q4 2022 and fell as low as -$76.3 million in Q1 2022.
• Historically, Income towards Parent Company has averaged -$3.5 million across 5 years, with a median of -$21.0 million in 2023.
• Across the five-year window, Income towards Parent Company sank 305.96% in 2022 and jumped 5420.84% in 2026, its largest moves.
• Year by year, Income towards Parent Company stood at $153.2 million in 2022, then tumbled by 90.78% to $14.1 million in 2023, then slumped by 292.36% to -$27.2 million in 2024, then soared by 151.16% to $13.9 million in 2025, then jumped by 919.31% to $141.7 million in 2026.
• Per Business Quant data, the three most recent Income towards Parent Company figures were $141.7 million in Q1 2026, $13.9 million in Q4 2025, and -$31.7 million in Q3 2025.